Jones Financial Companies’s VanEck Pharmaceutical ETF PPH Stock Holding History

Jones Financial Companies’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$907K	Sell	8,285 -2,009	-20%	-$208K	﹤0.01%	1950
2026 Q1	$1.04M	Buy	10,294 +558	+6%	+$59.4K	﹤0.01%	1702
2025 Q4	$1M	Buy	9,736 +6,133	+170%	+$597K	﹤0.01%	1231
2025 Q3	$313K	Buy	3,603 +363	+11%	+$31.8K	﹤0.01%	1602
2025 Q2	$283K	Buy	3,240 +390	+14%	+$33.8K	﹤0.01%	1515
2025 Q1	$258K	Sell	2,850 -2,854	-50%	-$257K	﹤0.01%	1388
2024 Q4	$492K	Buy	5,704 +5,408	+1,827%	+$489K	﹤0.01%	1007
2024 Q3	$28.1K	Buy	296 +145	+96%	+$13.8K	﹤0.01%	1838
2024 Q2	$13.8K	Buy	151 +1	+0.7%	+$89	﹤0.01%	1656
2024 Q1	$13.6K	Buy	+150	New	+$13.1K	﹤0.01%	996

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Jones Financial Companies's PPH Position: Q2 2026 in Review

Jones Financial Companies reduced its VanEck Pharmaceutical ETF (PPH) stake by 20% in Q2 2026, selling an estimated $208K and leaving 8,285 shares worth $907K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Jones Financial Companies first reported a position in PPH in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.04M in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Jones Financial Companies held 8,285 shares of VanEck Pharmaceutical ETF worth $907K as of Q2 2026.
Jones Financial Companies sold 2,009 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $208K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1950 holding.
Jones Financial Companies first reported a position in VanEck Pharmaceutical ETF in Q1 2024 and has held it in 10 quarters since.
Jones Financial Companies's VanEck Pharmaceutical ETF position peaked at $1.04M in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.